中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [11]
西安光学精密机械研究... [9]
广州地球化学研究所 [1]
中国科学院大学 [1]
地球化学研究所 [1]
采集方式
OAI收割 [22]
iSwitch采集 [1]
内容类型
期刊论文 [20]
会议论文 [3]
发表日期
2024 [1]
2023 [3]
2022 [2]
2021 [5]
2020 [1]
2019 [4]
更多
学科主题
环境地球化学 [1]
筛选
浏览/检索结果:
共23条,第1-10条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-
d
]pyrimidin-7(6
H
)-one" Scaffold for the Treatment of B Cell Lymphoma
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 4, 页码: 2884-2906
作者:
Liang, Xuewu
;
Yu, Haolan
;
Liang, Renwen
;
Feng, Zhuanghui
;
Saidahmatov, Abdusaid
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2024/04/09
Structure-based drug discovery of novel fused- pyrazolone carboxamide derivatives as potent and selective AXL inhibitors
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4918-4933
作者:
Fang, Feifei
;
Dai, Yang
;
Wang, Hao
;
Ji, Yinchun
;
Liang, Xuewu
  |  
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2024/01/26
derivatives
Antitumor drug development
Potential AXL inhibitor
Antitumor activity
Structure-based drug design
Fused-pyrazolone carboxamide
The new direction of drug development: Degradation of undruggable targets through targeting chimera technology
期刊论文
OAI收割
MEDICINAL RESEARCH REVIEWS, 2023, 页码: 54
作者:
Liang, Xuewu
;
Ren, Hairu
;
Han, Fengyang
;
Liang, Renwen
;
Zhao, Jiayan
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2024/01/16
chimeric design
degradation System
PROTAC
targeted degradation technology
undruggable targets
Construction of Diversified Penta-Spiro-Heterocyclic and Fused-Heterocyclic Frameworks with Potent Antitumor Activity
期刊论文
OAI收割
CHEMISTRY-A EUROPEAN JOURNAL, 2023, 页码: 7
作者:
Liu, Qi
;
Liu, Xuyi
;
Li, Yazhou
;
Zhou, Yu
;
Zhao, Linxiang
  |  
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2023/10/17
spiro
fused-heterocyclic frameworks
substrate- and pH- controlled strategies
C-H activation
[4+1] and [4+2] annulation
antitumor
indazolone
Discovery of Novel Imidazo[4,5-c]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 页码: 21
作者:
Liang, Xuewu
;
Xie, Yongle
;
Liu, Xuyi
;
Xu, Hui
;
Ren, Hairu
  |  
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/11/11
Discovery of Novel Pyrrolo[2,3-d]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 2, 页码: 1243-1264
作者:
Liang, Xuewu
;
Tang, Shuai
;
Liu, Xuyi
;
Liu, Yingluo
;
Xu, Qifu
  |  
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/06/15
I-2-induced cascade cyclization and dearomatization of indoles for the highly efficient synthesis of iodinated and vinylic spiroindolenines
期刊论文
OAI收割
GREEN CHEMISTRY, 2021, 卷号: 23, 期号: 22, 页码: 9165-9171
作者:
Wei, Xiaohui
;
Liang, Xuewu
;
Li, Yazhou
;
Liu, Qi
;
Liu, Xuyi
  |  
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2021/12/16
Identification of Novel Fused Heteroaromatics-Based MALT1 Inhibitors by High-Throughput Screening to Treat B Cell Lymphoma
期刊论文
OAI收割
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 64, 期号: 13, 页码: 9217-9237
作者:
Liang, Xuewu
;
Sun, Chenxia
;
Li, Chunpu
;
Yu, Haolan
;
Wei, Xiaohui
  |  
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2021/08/17
Solving, analyzing, manufacturing, and experimental testing of thickness distribution for a cycloid-like variable curvature mirror
期刊论文
OAI收割
Optics Express, 2021, 卷号: 29, 期号: 12, 页码: 18010-18025
作者:
Xie, Xiaopeng
;
Xu, Liang
;
Wang, Yongjie
;
Shen, Le
;
Fan, Xuewu
  |  
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2021/06/21
MALT1 as a promising target to treat lymphoma and other diseases related to MALT1 anomalies
期刊论文
OAI收割
MEDICINAL RESEARCH REVIEWS, 2021, 页码: 35
作者:
Liang, Xuewu
;
Cao, YiChun
;
Li, Chunpu
;
Yu, Haolan
;
Yang, Chenghua
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2021/05/24
DLBCL
MALT lymphoma
MALT1
MALT1 inhibitors
NF‐
κ
B pathway